The European Commission finally approved the Astra Zeneca COVID-19 vaccine. However, its effectiveness among seniors in the elderly is questionable, as it was tested only on people under 55. The first doses of the vaccine will be delivered to EU Member States within a week. 

"In Poland, this vaccine will be used by people between 18 and 60 years of age. We expect the first delivery of Astra Zeneca vaccine next week. And also next week, we would like to start vaccinating teachers." stated Prime Minister's chief of staff Michał Dworczyk. 

A vaccine crisis caused by slow delivery schedules is visible across the European Union. So far about a million people in Poland, 2.5 million in Germany and 1.5 million in France have received their first dose. The situation is much better in Great Britain, where 9 million people have already received vaccines. The British government approved the Astra Zeneca vaccine at the end of December, ordering 100 million doses immediately, which the company promised to deliver by the end of the first quarter of this year. The European Union has so far obtained a guarantee of 40 million doses.

"First, the bare data says we are 3 to 6 months behind the UK and the US. Secondly, their vaccination rates are five times higher than in the EU, meaning 100 vaccinations per 1000 residents. Complete failure. Bureaucracy, long deliberations, procrastination, bad negotiation tactics. They went about it like accountants, that is, they wanted to lower the price, apart from the fact that there are economic losses worth billions of euros and an even more valuable loss of human life." commented Jacek Saryusz-Wolski, an MEP from European Conservatives. 

In the face of the vaccine crisis, the European Union is also considering approval of the Russian vaccine Sputnik V. Peer by Lancet review supports the Russian claim of 91 percent efficacy.